Literature DB >> 31564631

A novel density-volume calcium score by non-contrast CT predicts coronary plaque burden on coronary CT angiography: Results from the MACS (Multicenter AIDS cohort study).

Rine Nakanishi1, Joseph A Delaney2, Wendy S Post3, Christopher Dailing4, Michael J Blaha3, Frank Palella5, Mallory Witt6, Todd T Brown7, Lawrence A Kingsley8, Kazuhiro Osawa4, Indre Ceponiene4, Negin Nezarat4, Sina Rahmani4, Mitsuru Kanisawa4, Lisa Jacobson9, Matthew J Budoff4.   

Abstract

BACKGROUND: The purpose of this study is to determine if a new score calculated with coronary artery calcium (CAC) density and volume is associated with total coronary artery plaque burden and composition on coronary CT angiography (CCTA) compared to the Agatston score (AS).
METHODS: We identified 347 men enrolled in the Multicenter AIDS cohort study who underwent contrast and non-contrast CCTs, and had CAC>0. CAC densities (mean Hounsfield Units [HU]) per plaque) and volumes on non-contrast CCT were measured. A Density-Volume Calcium score was calculated by multiplying the plaque volume by a factor based on the mean HU of the plaque (4, 3, 2 and 1 for 130-199, 200-299, 300-399, and ≥400HU). Total Density-Volume Calcium score was determined by the sum of these individual scores. The semi-quantitative partially calcified and total plaque scores (PCPS and TPS) on CCTA were calculated. The associations between Density-Volume Calcium score, PCPS and TPS were examined.
RESULTS: Overall, 2879 CAC plaques were assessed. Multivariable linear regression models demonstrated a stronger association between the log Density-Volume Calcium score and both the PCPS (β 0.99, 95%CI 0.80-1.19) and TPS (β 2.15, 95%CI 1.88-2.42) compared to the log of AS (PCPS: β 0.77, 95%CI 0.61-0.94; TPS: β 1.70, 95%CI 1.48-1.94). Similar results were observed for numbers of PC or TP segments.
CONCLUSION: The new CAC score weighted towards lower density demonstrated improved correlation with semi-quantitative PC and TP burden on CCTA compared to the traditional AS, which suggests it has utility as an alternative measure of atherosclerotic burden.
Copyright © 2020 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium density; Calcium volume; Coronary artery calcium; Coronary computed tomographic angiography; Human immunodeficiency virus

Mesh:

Year:  2019        PMID: 31564631      PMCID: PMC7089811          DOI: 10.1016/j.jcct.2019.09.016

Source DB:  PubMed          Journal:  J Cardiovasc Comput Tomogr        ISSN: 1876-861X


  27 in total

1.  Improving the relationship between coronary artery calcium score and coronary plaque burden: addition of regional measures of coronary artery calcium distribution.

Authors:  Rajesh Tota-Maharaj; Mouaz H Al-Mallah; Khurram Nasir; Waqas T Qureshi; Roger S Blumenthal; Michael J Blaha
Journal:  Atherosclerosis       Date:  2014-11-24       Impact factor: 5.162

2.  Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial.

Authors:  Yadon Arad; Louise A Spadaro; Marguerite Roth; David Newstein; Alan D Guerci
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

3.  Variation in atherosclerotic plaque composition according to increasing coronary artery calcium scores on computed tomography angiography.

Authors:  Khurram Nasir; Juan J Rivera; Yeonyee E Yoon; Sung-A Chang; Sang-il Choi; Eun-Ju Chun; Dong-Joo Choi; Matthew J Budoff; Roger S Blumenthal; Hyuk-Jae Chang
Journal:  Int J Cardiovasc Imaging       Date:  2010-04-29       Impact factor: 2.357

4.  HIV infection is associated with an increased prevalence of coronary noncalcified plaque among participants with a coronary artery calcium score of zero: Multicenter AIDS Cohort Study (MACS).

Authors:  T S Metkus; T Brown; M Budoff; L Kingsley; F J Palella; M D Witt; X Li; R T George; L P Jacobson; W S Post
Journal:  HIV Med       Date:  2015-05-13       Impact factor: 3.180

5.  Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial.

Authors:  E S Houslay; S J Cowell; R J Prescott; J Reid; J Burton; D B Northridge; N A Boon; D E Newby
Journal:  Heart       Date:  2006-01-31       Impact factor: 5.994

6.  Use of cardiac CT angiography imaging in an epidemiology study - the Methodology of the Multicenter AIDS Cohort Study cardiovascular disease substudy.

Authors:  Yalçın Hacıoğlu; Mohit Gupta; Tae Young Choi; Richard T George; Christopher R Deible; Lisa P Jacobson; Mallory D Witt; Frank J Palella; Wendy S Post; Matthew J Budoff
Journal:  Anadolu Kardiyol Derg       Date:  2013-01-30

7.  Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: a quantitative pathologic comparison study.

Authors:  D B Simons; R S Schwartz; W D Edwards; P F Sheedy; J F Breen; J A Rumberger
Journal:  J Am Coll Cardiol       Date:  1992-11-01       Impact factor: 24.094

8.  The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.

Authors:  R A Kaslow; D G Ostrow; R Detels; J P Phair; B F Polk; C R Rinaldo
Journal:  Am J Epidemiol       Date:  1987-08       Impact factor: 4.897

9.  Coronary calcium as a predictor of coronary events in four racial or ethnic groups.

Authors:  Robert Detrano; Alan D Guerci; J Jeffrey Carr; Diane E Bild; Gregory Burke; Aaron R Folsom; Kiang Liu; Steven Shea; Moyses Szklo; David A Bluemke; Daniel H O'Leary; Russell Tracy; Karol Watson; Nathan D Wong; Richard A Kronmal
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

10.  Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Cathy Anne Pinto; Christopher Tong; Ash Rafique; Richard Hargeaves; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Nucl Med       Date:  2008-05-15       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.